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WARNING 
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University in accordance with section 113P of the Copyright Act 1968 (Act). 
The material in this communication may be subject to copyright under the Act.  
Any further reproduction or communication of this material by you may be the subject of copyright 
protection under the Act. 
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           Charles Darwin University 
                    Final Examination  
 
 
PHA312 – Infectious Diseases 
DURATION 
 
Reading Time: 10 minutes 
Writing Time: 180 minutes 
 
INSTRUCTIONS TO CANDIDATES 
The examination has TWO (A and B) Sections: 
  
Section A contains short answer questions: Answer All questions. Total marks allocated: 50 
Suggested time allocation: Ninety (90) minutes  
 
Section B contains case studies questions: Answer All questions. Total marks allocated: 50 
Suggested time allocation: Ninety (90) minutes  
 
EXAM CONDITIONS 
You may begin writing from the commencement of the examination session.  The reading time indicated above is 
provided as a guide only. 
This is a CLOSED BOOK examination 
Any non-programmable calculator is permitted 
No handwritten notes are permitted 
No dictionaries are permitted 
 
ADDITIONAL AUTHORISED MATERIALS EXAMINATION MATERIALS TO BE SUPPLIED 
 
No additional printed material is permitted 
 
 
1 x 8 Page Book 
1 x 20 Page Book 
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Section A 
Short Answer Questions 
Answer All Questions 
Total No of Marks for this Section:  50 
This section should be answered on the 20-page Answer Booklet provided.  Please ensure that your 
name and student number have been written on the completed Answer Booklet. 






Briefly discuss the mechanisms by which microorganisms develop resistance to any TWO of the 




c. Vancomycin  
 





a. Name ONE virus and ONE bacterium which are the most common pathogens causing otitis 
media. List THREE indications for which antibiotics treatment should be considered. What 
antibiotic treatment is recommended if drug-resistance is present? 
 
b. Name THREE conditions in which antibiotic prophylaxis is recommended to prevent infective 
endocarditis. 





Prophylaxis may be an appropriate form of therapy in certain situations. 
a. Define what is meant by prophylactic therapy and contrast prophylactic therapy with pre-
emptive and empiric therapy. 
 
b. Discuss the key factors to consider when deciding if prophylactic therapy is appropriate for an 
individual.  
 
c. Give TWO examples of situations in which prophylactic therapy would be appropriate. 
(Marks 3 + 3 + 2 = 8)  
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a. Outline the factors that are important in selecting antimicrobials to treat central nervous system 
infections. 
b. List TWO most common causative organisms for meningitis and describe their pathogenesis 
(your answer should include mode of infection, risk factors and prognosis). 







Briefly discuss the pathogenesis and key management principles of urinary tract infection. 
(Pathogenesis should include common pathogens, risk factors and prognosis.) 
 





Sepsis resulting from a bacterial infection can be a life-threatening illness. 
 
Describe the key features of bacterial sepsis including a clinical definition, early general symptoms that 
may help identify cases, most common sources of infection and possible pathogens, pathogenesis, 
prognosis, and key management principles. 






a. Name TWO bacterial species that primarily cause sexually transmitted infections. 
 
b. For each species, give the full genus and species name of the causative organism, describe the 
symptoms and possible complications associated with urogenital infection, describe the high 
incidence population groups, and describe the key management principles. (You can use a table 
to elaborate your answer). 




END OF SECTION A 
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Section B 
Case Study Questions 
Answer all questions 
Total No of Marks for this Section: 50  
This section should be answered in the 20-page Answer Booklet provided. 




A 75-year old female presents to hospital upon experiencing influenza-like symptoms and generally 
feeling unwell for one week. She has non-productive cough and describes pain in her chest. 
She has a past medical history of hypertension and high cholesterol, diagnosed 20 years ago; she 
suffered from a mild stroke 2 years ago, which has left her with slurred speech. She also has arthritis in 
both knees. Her current regular medications include Ramipril, low dose aspirin, atorvastatin, 
paracetamol and oxycodone. 
She lives in her own home independently but requires assistance with some activities of daily living such 
as shopping and cleaning. 
 
On examination, she is found to be moderately dehydrated. Physical examination and chest X-ray (CXR) 
show evidence of right middle lobe consolidation but the remainder of the chest is clear. Vital signs are 
as follows: 
 
BP = 118/63 
HR 90 bpm 
RR 18 breath/min 
Temperature 37.4°C 
SatO2 87%  
 
Full Blood Count U/E 
RCC 4.05 Na+ 134  
Platelets 168 K+ 3.6  
WCC 14.2 eGFR 37  
Neutrophil 11.90 CRP 280 
Lymphocytes 0.65   
Monocytes 0.13   
 
A sputum sample is collected and sent for MCS testing. Preliminary results indicated a mixed growth and 
normal oral flora. A second sputum sample was ordered.  
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Questions (for case 1) 
 
A. Briefly discuss the severity of her condition with reference to specific parameters. 
 (Marks 4)  
 
B. Describe the pathogenesis of pneumonia in this patient.  




C. What empirical therapy would you recommend for the treatment of this patient? (Your answer 
should also include the rationale for your recommendation and any specific considerations.)  







Three days after the initiation of empirical therapy, the symptoms of pneumonia are improving, and the 
second sputum MCS test finds no growth after 48 hours.  
However, the patient develops a sudden onset of painful skin rash on the right side of her chest. She is 





D. Discuss the pathogenesis of shingles in this patient. 
(Discussion of pathogenesis should include route of infection, risk factors and pathogens involved.) 
 
(Marks: 3)  
 
E. Outline the treatment plan you would recommend for managing the shingles.  
(Your answer should also include the rationale for your recommendation and any specific 
considerations.) 
 
(Marks: 3)  
 
 
(Total: 20 marks) 
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Case 2  
A 33-year old female presents to her GP complaining of pain during urination (dysuria) and lower 
abdominal pain for 2 days. She has a history of recurrent urinary tract infections. 
She has type I diabetes diagnosed when she was 15 years old. Her diabetes is well controlled by insulin 
and lifestyle modifications. She is allergic to penicillin (severe rash and laryngeal oedema develop if she 
is exposed to chemically related agents.) 
She cannot recall the date of her last menstrual period; a home pregnancy test done 2 days ago was 
positive. 
 
On examination, the patient is visibly uncomfortable but afebrile to touch.  BP = 134/68, HR 81 bpm. 
 
Urine dipstick test:  
 





RBC negative  
 
She is diagnosed with cystitis. Empirical therapy was commenced with cephalexin 
 
Questions  




B. Outline a management plan (further investigations, treatment and prophylaxis) that you would 
recommend for this patient.  
 
 (Marks 5) 
 
 





D. What follow up would you suggest for the patient? 
(Marks 2) 
 
 (Total: 15 marks) 
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Case 3 
Mr EB is a Darwin resident, originally from Papua New Guinea (PNG). He has presented with a history of 
three days of fever, headache, and mild nausea.  
A clinical history revealed that Mr EB had returned to Darwin from a trip to PNG 9 months ago. He had 
originally planned a holiday to Argentina and had been prescribed chloroquine as malaria prophylaxis. 
At the last minute he had to cancel that trip to return to PNG to visit a sick family member. As he 
already had the chloroquine, he used it for prophylaxis for his PNG trip. 
A peripheral blood sample is taken, and thick and thin blood smears are prepared in the pathology 
laboratory. As it is a Sunday, a technician views the slide, however a pathologist will not be able to view 
the slide and prepare a report until the following day. By telephone, the technician reports that she 
observed malaria parasites at 4 parasites per 1000 red blood cells, with ring and schizont forms with 20 




A. What species of malaria is likely responsible for this patient’s infection and which of the above 
information indicates this? How does this rule out other possible species? 
(Marks 5) 
 
B. What are appropriate anti-malarial drugs for treatment for this patient, and what stages of the 
parasite’s life cycle do they target? 
(Marks 5) 
 
C. What important laboratory test must be carried out before the treatment can be initiated and why? 
(Marks 2) 
 
D. Why was the prescribed chloroquine not effective as prophylaxis in this case? 
(Marks 3) 
(Total: 15 marks) 
END OF EXAM  
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Reference Ranges  
Urea and electrolytes (U&E) 
Na 135.0-145.0 mmol/L 
K 3.50-4.50 mmol/L (plasma)   
3.8-4.9 mmol/L (serum) 
Cl 95-110 mmol/L 
Urea 3.8-8.0 mmol/L 
Creatinine 60-100 micromol/L 
eGFR > 90 mL/min/1.73 m2 
Osmolality (serum) 275-295 mOsm/kg 
Anion gap 13-17 mEq/L 
 
Calcium, magnesium and phosphate (CMP) 
Ca (total) 2.1-2.6 mmol/L 
Ca (ionised) 1.16-1.3 mmol/L 
PO43- 0.8-1.5 mmol/L 
Mg 0.8-1.0 mmol/L 
 
Arterial blood gas (ABG) 
pH 7.35-7.45 
pO2 80-110 mmHg 
pCO2 35-45 mmHg 
Bicarbonate (HCO3-) 22-33 mmol/L 
 
Liver function test (LFT) 
ALT <30 U/L 
AST <40 U/L 
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ALP 30-100 U/L 
GGT <30 U/L (female) 
<50 U/L (male) 
Bilirubin (total) <20 umol/L 
Bilirubin (conjugated) <4.0 umol/L 
Albumin 32-45 g/L 
Total protein 63-80 g/L 
Pancreatic lipase 8 – 78 U/L 
 
Carbohydrate metabolism 
BSL (random) 3.0-7.7 mmol/L 
BSL (fasting) 3.0-5.5 mmol/L 
HbA1c(non-DM) 4.3-5.7% (NGSP) 
23-39 mmol/mol (IFCC) 
HbA1c (DM) therapeutic target<7% * 
 
Fasting lipid biochemistry 
Total cholesterol <5.5 mmol/L 
LDL 2-3.4 mmol/L 
HDL >1 mmol/L 
Non-HDL cholesterol <2.5 mmol/L 
Triglyceride (TG) <1.7 mmol/L 
 
Full blood examination (FBE) 
Hb 140-174 g/L (male) 
120-160 g/L (female)  
RCC 4.50-5.50 x1012/L (male) 
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4.0- 5.0 x1012/L (female)  
Haematocrit 0.42-0.52 or 42-52 % (male) 
0.36-0.48 or 36-48%(female) 
MCV 80.0-100.0 fL 
RDW 11.5-14.5 % 
Platelets 150-450 x109/L) 
WCC 4.0-11.0 (x109 /L) 
Neutrophil 40-80% 
2.0-7.5 x109 /L 
Lymphocytes 20-40% 




0.0-0.4 x109 /L 
Basophils <2% 
0.0-0.1 x109 /L 
 
Thyroid function test (TFT) 
TSH 0.4-5.0 mU/L 
T4 (free) 10-25 pmol/ 
T3 (free) 3.0-6.5 pmol/L 
 
Iron Studies 
Serum Iron  227mcg/dL Men 50 to 150mcg/dL 
Women 35-145mcg/dL 
Total Iron Binding Capacity 350 mcg/dL 250-400mcg/dL 
 
Serum Ferritin 4500g/L Men 20-300ng/L 
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Women 20-200ng/L 




Troponin T <0.01 μg/L 
CRP <3 mg/L 
D-dimer <500 μg/L 
BNP <20 nmol/L 
 
